Literature DB >> 2612985

Clot lysis by gastric juice: an in vitro study.

S E Patchett1, H Enright, N Afdhal, W O'Connell, D P O'Donoghue.   

Abstract

Gastric juice from patients with peptic ulcer disease and from patients with no upper gastrointestinal abnormality was studied in order to assess its effect on a formed fibrin clot. In both groups of patients gastric juice caused a marked increase in fibrinolysis as evidenced by a shortening of the euglobulin clot lysis time. This plasmin mediated fibrinolytic activity was found to be heat labile and only present in an acid environment. Addition of tranexamic acid or sucralfate to gastric juice almost completely reversed this effect, whereas pepstatin was only partially effective. It is probable that acid dependent proteases other than pepsin are responsible for the marked fibrinolysis. The ulcer healing agent sucralfate might be useful in those patients at risk of bleeding or rebleeding from active peptic ulcer disease.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2612985      PMCID: PMC1434462          DOI: 10.1136/gut.30.12.1704

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  12 in total

1.  Experience with antipeptic agents.

Authors:  A Berstad; H A Holm; E Kittang
Journal:  Scand J Gastroenterol Suppl       Date:  1979

2.  Fibrinolytic activity in gastric venous blood. A comparison between normal and diseased stomachs.

Authors:  T E O'Brien; H Hadley; M H Irving
Journal:  Gastroenterology       Date:  1979-03       Impact factor: 22.682

3.  Gastric fibrinolysis.

Authors:  I M Nilsson; S E Bergentz; U Hedner; K Kullenberg
Journal:  Thromb Diath Haemorrh       Date:  1975-11-15

4.  Gastric fibrinolysis. A possible aetiological link with peptic ulcer.

Authors:  H T Cox; L Poller; J M Thomson
Journal:  Lancet       Date:  1967-06-17       Impact factor: 79.321

5.  Upper gastrointestinal bleeding.

Authors:  J N Crook; L W Gray; F C Nance; I Cohn
Journal:  Ann Surg       Date:  1972-05       Impact factor: 12.969

6.  Continuous intravenous infusions of famotidine maintain high intragastric pH in duodenal ulcer.

Authors:  H S Merki; L Witzel; D Kaufman; M Kempf; J Neumann; J Röhmel; R P Walt
Journal:  Gut       Date:  1988-04       Impact factor: 23.059

7.  Comparison of surgical and medical management of bleeding peptic ulcers.

Authors:  K D Vellacott; M W Dronfield; M Atkinson; M J Langman
Journal:  Br Med J (Clin Res Ed)       Date:  1982-02-20

8.  A study of the factors influencing mortality rates from gastrointestinal haemorrhage.

Authors:  R Allan; P Dykes
Journal:  Q J Med       Date:  1976-10

9.  Tranexamic acid and upper gastrointestinal haemorrhage--a double-blind trial.

Authors:  J C Biggs; T B Hugh; A J Dodds
Journal:  Gut       Date:  1976-09       Impact factor: 23.059

10.  Cimetidine and tranexamic acid in the treatment of acute upper-gastrointestinal-tract bleeding.

Authors:  D Barer; A Ogilvie; D Henry; M Dronfield; D Coggon; S French; S Ellis; M Atkinson; M Langman
Journal:  N Engl J Med       Date:  1983-06-30       Impact factor: 91.245

View more
  31 in total

Review 1.  Management of haematemesis and melaena.

Authors:  K Palmer
Journal:  Postgrad Med J       Date:  2004-07       Impact factor: 2.401

2.  High-dose vs low-dose proton pump inhibitors for upper gastrointestinal bleeding: a meta-analysis.

Authors:  Liu-Cheng Wu; Yun-Fei Cao; Jia-Hao Huang; Cun Liao; Feng Gao
Journal:  World J Gastroenterol       Date:  2010-05-28       Impact factor: 5.742

3.  Pharmacological Treatment in Upper Gastrointestinal Bleeding.

Authors:  Kelvin L Y Lam; John C T Wong; James Y W Lau
Journal:  Curr Treat Options Gastroenterol       Date:  2015-12

4.  Medical treatment of bleeding peptic ulcer: old drugs, new regimens.

Authors:  A Arora; R K Tandon
Journal:  Gut       Date:  1991-11       Impact factor: 23.059

5.  Intravenous esomeprazole for prevention of recurrent peptic ulcer bleeding.

Authors:  Alan B R Thomson
Journal:  Curr Gastroenterol Rep       Date:  2009-10

Review 6.  Comparing intravenous and oral proton pump inhibitor therapy for bleeding peptic ulcers following endoscopic management: a systematic review and meta-analysis.

Authors:  Alberto Tringali; Raffaele Manta; Mariano Sica; Gabrio Bassotti; Riccardo Marmo; Massimiliano Mutignani
Journal:  Br J Clin Pharmacol       Date:  2017-03-21       Impact factor: 4.335

7.  Role of proton pump inhibitors in the management of peptic ulcer bleeding.

Authors:  Hwai-Jeng Lin
Journal:  World J Gastrointest Pharmacol Ther       Date:  2010-04-06

Review 8.  Appropriate use of intravenous proton pump inhibitors in the management of bleeding peptic ulcer.

Authors:  Venodhar R Julapalli; David Y Graham
Journal:  Dig Dis Sci       Date:  2005-07       Impact factor: 3.199

Review 9.  Gastric acid inhibition in the treatment of peptic ulcer hemorrhage.

Authors:  Kevin A Ghassemi; Thomas O G Kovacs; Dennis M Jensen
Journal:  Curr Gastroenterol Rep       Date:  2009-12

Review 10.  Fasting for haemostasis in children with gastrointestinal bleeding.

Authors:  Shuang-Hong Luo; Qin Guo; Guan J Liu; Chaomin Wan
Journal:  Cochrane Database Syst Rev       Date:  2016-05-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.